Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.

Mercer, Louise K; Galloway, James B; Lunt, Mark; Davies, Rebecca; Low, Audrey L S; Dixon, William G; Watson, Kath D; Symmons, Deborah P M; Hyrich, Kimme L

Mercer, Louise K; Galloway, James B; Lunt, Mark; Davies, Rebecca; Low, Audrey L S; Dixon, William G; Watson, Kath D; Symmons, Deborah P M; Hyrich, Kimme L.

Afiliación

Mercer LK; Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
Galloway JB; Department of Rheumatology, King's College London, London, UK.
Lunt M; Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
Davies R; Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
Low AL; Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
Dixon WG; Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
Watson KD; NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust and University of Manchester Partnership, Manchester, UK.
Hyrich KL; Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.

Ann Rheum Dis ; 76(3): 497-503, 2017 Mar.

Article en En | MEDLINE | ID: mdl-27502891

Asunto(s)

Antirreumáticos/uso terapéutico; Artritis Reumatoide/tratamiento farmacológico; Artritis Reumatoide/epidemiología; Linfoma/epidemiología; Factor de Necrosis Tumoral alfa/antagonistas & inhibidores; Adalimumab/uso terapéutico; Adulto; Anciano; Estudios de Casos y Controles; Etanercept/uso terapéutico; Femenino; Estudios de Seguimiento; Humanos; Incidencia; Infliximab/uso terapéutico; Masculino; Persona de Mediana Edad; Estudios Prospectivos; Sistema de Registros; Medición de Riesgo; Reino Unido/epidemiología

Palabras clave

Anti-TNF; Epidemiology; Rheumatoid Arthritis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Artritis Reumatoide / Factor de Necrosis Tumoral alfa / Antirreumáticos / Linfoma Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Ann Rheum Dis Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google